WASHINGTON, May 2 – When North Carolina State University initiated its new bioinformatics center in March, several leading industry executives were prominently in attendance. Their commitment to the institute, including promises to fund research and offer graduate student internships, underscores a growing fact of life in the life science community: The line between academia and industry is becoming increasingly blurred.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.